SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN PEDIATRIC MALIGNANCIES

By Ben Arush M.   Schenzer P.   Maurice S.   Elhasid R.   Postovsky S.   Barak A.   Haimi M.   Zeidman I.   Hayari L.   Livne E.  

Pediatric Hematology and Oncology, Vol. 22, Iss. 6, 2005-09 ,pp. : 513-524

Informa Healthcare

Access to resources Recommend Favorite

Controversies in the Role of Radiotherapy in the Treatment of Pediatric Hodgkin Lymphoma

By Henry Meret   Savaşan Süreyya  

The Indian Journal of Pediatrics, Vol. 80, Iss. 10, 2013-10 ,pp. : 863-869

Springer Publishing Company

Access to resources Recommend Favorite

SERUM CA 125 LEVELS IN CHILDREN WITH NON-HODGKIN'S LYMPHOMA

By Kutluk Tezer   Varan Ali   Erbas Belkis   Buyukpamukcu Munevver  

Pediatric Hematology and Oncology, Vol. 16, Iss. 4, 1999-07 ,pp. : 311-319

Informa Healthcare

Access to resources Recommend Favorite

Pediatric Hodgkin Lymphoma: CT Features at Presentation, on Treatment and its Prognostic Significance

By Dinesh Kumar  

The Indian Journal of Pediatrics, Vol. 78, Iss. 5, 2011-05 ,pp. : 549-554

Springer Publishing Company

Access to resources Recommend Favorite

COULD CISPLATIN AS A FRONT-LINE TREATMENT IN CHILDHOOD NON-HODGKIN'S LYMPHOMA BE A PROMISING THERAPY?

By Papadopoulou Athina L.   Moschovi Mary   Panagopoulou-Cristaki Marili   Anagnostou-Keramida Dimitra   Vliet-Constantinidou Catherine Van   Botsonis Athanasios   Tsangaris George Th.   Tzortzatou-Stathopoulou Fotini  

Pediatric Hematology and Oncology, Vol. 16, Iss. 4, 1999-07 ,pp. : 341-346

Informa Healthcare

Access to resources Recommend Favorite